Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
44,444
$1.05
$46.67K
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
122,220
$1.32
$161.33K
William H Rastetter
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Robert S Epstein
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 18,631,912
History held since 7 Oct 2013